Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Dennis LangerDirector | Quoin PharmaceuticalsQNRX | Open-market buy | 25/10/14 | 25/10/15 | 15,152 sh | $8.49 | $128,640.48 | +1515200.0% |
Anthony James CulverwellDirector | Quoin PharmaceuticalsQNRX | Open-market buy | 24/12/23 | 24/12/27 | 100,000 sh | $0.45 | $45,000 | +31545.7% |
Gordon DunnCFO | Quoin PharmaceuticalsQNRX | Open-market buy | 24/12/23 | 24/12/27 | 122,221 sh | $0.45 | $54,999.45 | +423.6% |
Quoin PharmaceuticalsQNRX | Open-market buy | 24/12/23 | 24/12/27 | 555,556 sh | $0.45 | $250,000.2 | +1179.7% | |
Quoin PharmaceuticalsQNRX | Open-market buy | 24/12/23 | 24/12/27 | 555,556 sh | $0.45 | $250,000.2 | +1175.7% | |
Quoin PharmaceuticalsQNRX | Open-market buy | 24/09/09–24/09/10 | 24/09/11 | 28,856 sh5 trades | $0.80avg. | $23,204.8 | No record | |
Quoin PharmaceuticalsQNRX | Open-market buy | 24/09/03–24/09/04 | 24/09/05 | 37,735 sh4 trades | $0.76avg. | $28,863.01 | +403.3% | |
Quoin PharmaceuticalsQNRX | Open-market buy | 24/09/03–24/09/04 | 24/09/05 | 37,894 sh4 trades | $0.77avg. | $29,016.12 | +404.9% | |
Dennis LangerDirector | Quoin PharmaceuticalsQNRX | Open-market sale | 24/06/07 | 24/06/10 | 297 sh | $0.73 | $216.81 | −84.9% |